AKIP1 | A kinase (PRKA) interacting protein 1 | | | | | | Expressed in all |
AKIRIN1 | Akirin 1 | | | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
AKR7A2 | Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | Enzymes Plasma proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT1S1 | AKT1 substrate 1 (proline-rich) | | | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKTIP | AKT interacting protein | Plasma proteins
| | | | | Expressed in all |
ALAS1 | Aminolevulinate, delta-, synthase 1 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ALDH16A1 | Aldehyde dehydrogenase 16 family, member A1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALDH18A1 | Aldehyde dehydrogenase 18 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ALDH1B1 | Aldehyde dehydrogenase 1 family, member B1 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALDH7A1 | Aldehyde dehydrogenase 7 family, member A1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALKBH2 | AlkB, alkylation repair homolog 2 (E. coli) | Enzymes
| | | | | Expressed in all |
ALKBH3 | AlkB, alkylation repair homolog 3 (E. coli) | | | | | | Expressed in all |
ALKBH8 | AlkB, alkylation repair homolog 8 (E. coli) | Enzymes
| | | | | Expressed in all |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ALYREF | Aly/REF export factor | Plasma proteins
| | | | | Expressed in all |
AMD1 | Adenosylmethionine decarboxylase 1 | Enzymes
| | | | | Expressed in all |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| | | | | Mixed |
AMOTL1 | Angiomotin like 1 | | | | | | Expressed in all |
AMPD2 | Adenosine monophosphate deaminase 2 | Enzymes
| | | | | Expressed in all |
AMPD3 | Adenosine monophosphate deaminase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
AMZ2 | Archaelysin family metallopeptidase 2 | Enzymes
| | | | | Expressed in all |
ANAPC11 | Anaphase promoting complex subunit 11 | | | | | | Expressed in all |
ANAPC16 | Anaphase promoting complex subunit 16 | | | | | | Expressed in all |
ANAPC2 | Anaphase promoting complex subunit 2 | | | | | | Expressed in all |
ANAPC7 | Anaphase promoting complex subunit 7 | Plasma proteins
| | | | | Expressed in all |
ANKIB1 | Ankyrin repeat and IBR domain containing 1 | Predicted secreted proteins
| | | | | Expressed in all |
ANKRD1 | Ankyrin repeat domain 1 (cardiac muscle) | Disease related genes
| | | | | Tissue enriched |
ANKRD11 | Ankyrin repeat domain 11 | Disease related genes
| | | | | Expressed in all |
ANKRD12 | Ankyrin repeat domain 12 | Cancer-related genes
| | | | | Expressed in all |
ANKRD13A | Ankyrin repeat domain 13A | | | | | | Expressed in all |
ANKRD13B | Ankyrin repeat domain 13B | | | | | | Mixed |
ANKRD17 | Ankyrin repeat domain 17 | Plasma proteins
| | | | | Expressed in all |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
ANKRD23 | Ankyrin repeat domain 23 | | | | | | Tissue enriched |
ANKRD27 | Ankyrin repeat domain 27 (VPS9 domain) | | | | | | Expressed in all |
ANKS3 | Ankyrin repeat and sterile alpha motif domain containing 3 | | | | | | Expressed in all |
ANKZF1 | Ankyrin repeat and zinc finger domain containing 1 | | | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
ANXA11 | Annexin A11 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ANXA3 | Annexin A3 | Plasma proteins
| | | | | Expressed in all |
ANXA5 | Annexin A5 | Disease related genes Plasma proteins
| | | | | Expressed in all |